BioCardia has been granted a patent for a needle-injection catheter system designed to deliver cellular aggregations to a patient’s heart. The system includes a catheter body with a helical needle for precise delivery into heart tissue. GlobalData’s report on BioCardia gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on BioCardia, Shapeable guide catheters was a key innovation area identified from patents. BioCardia's grant share as of May 2024 was 23%. Grant share is based on the ratio of number of grants to total number of patents.
Needle injection catheter system for delivering cellular aggregations to heart
A recently granted patent (Publication Number: US11986611B2) discloses a needle injection catheter system designed for delivering cellular aggregations to a patient's heart. The system includes a catheter body with a helical needle at the distal end, allowing for the injectable amount of cellular aggregations to be delivered into heart tissue. The helical needle has a bore size that ensures efficient delivery of the cellular aggregations, with specific diameter ranges specified for the lumens within the catheter system.
Moreover, the patent also outlines a method for delivering cellular aggregations to the heart, involving anchoring a helical needle in the heart chamber's endocardial wall and injecting the cellular aggregations through the helical lumen. The helical shape of the tissue tract formed by the needle prevents the flow back of cellular aggregates even after the needle is withdrawn. The method details the process of trans-endovascular advancement of a delivery catheter with the needle, emphasizing the importance of proper alignment using a guide catheter for accurate delivery to the target location on the endocardial wall.
To know more about GlobalData’s detailed insights on BioCardia, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.
